vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Chefs' Warehouse, Inc. (CHEF). Click either name above to swap in a different company.
Chefs' Warehouse, Inc. is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.1× Astrana Health, Inc.). Chefs' Warehouse, Inc. runs the higher net margin — 1.6% vs 0.7%, a 0.9% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 11.4%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 5.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Chefs' Warehouse, Inc. is a leading North American specialty food distributor that primarily serves independent restaurants, fine dining venues, hotels, catering firms, and other foodservice operators. It offers a curated portfolio of over 150,000 products including artisanal ingredients, specialty meats, seafood, dairy, pastries, and imported gourmet goods tailored for professional chefs.
ASTH vs CHEF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.1B |
| Net Profit | $6.6M | $17.4M |
| Gross Margin | — | 24.3% |
| Operating Margin | 1.9% | 3.1% |
| Net Margin | 0.7% | 1.6% |
| Revenue YoY | 42.9% | 11.4% |
| Net Profit YoY | 184.4% | 68.8% |
| EPS (diluted) | $0.12 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $1.0B | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $950.7M | ||
| Q4 24 | $665.2M | $1.0B | ||
| Q3 24 | $478.7M | $931.5M | ||
| Q2 24 | $486.3M | $954.7M |
| Q1 26 | — | $17.4M | ||
| Q4 25 | $6.6M | $21.7M | ||
| Q3 25 | $373.0K | $19.1M | ||
| Q2 25 | $9.4M | $21.2M | ||
| Q1 25 | $6.7M | $10.3M | ||
| Q4 24 | $-7.8M | $23.9M | ||
| Q3 24 | $16.1M | $14.1M | ||
| Q2 24 | $19.2M | $15.5M |
| Q1 26 | — | 24.3% | ||
| Q4 25 | — | 24.2% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 24.6% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 24.3% | ||
| Q3 24 | — | 24.1% | ||
| Q2 24 | — | 24.0% |
| Q1 26 | — | 3.1% | ||
| Q4 25 | 1.9% | 3.8% | ||
| Q3 25 | 2.0% | 3.8% | ||
| Q2 25 | 3.1% | 3.9% | ||
| Q1 25 | 3.3% | 2.4% | ||
| Q4 24 | 0.1% | 4.5% | ||
| Q3 24 | 5.9% | 3.4% | ||
| Q2 24 | 6.2% | 3.5% |
| Q1 26 | — | 1.6% | ||
| Q4 25 | 0.7% | 1.9% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 1.4% | 2.1% | ||
| Q1 25 | 1.1% | 1.1% | ||
| Q4 24 | -1.2% | 2.3% | ||
| Q3 24 | 3.4% | 1.5% | ||
| Q2 24 | 3.9% | 1.6% |
| Q1 26 | — | $0.40 | ||
| Q4 25 | $0.12 | $0.50 | ||
| Q3 25 | $0.01 | $0.44 | ||
| Q2 25 | $0.19 | $0.49 | ||
| Q1 25 | $0.14 | $0.25 | ||
| Q4 24 | $-0.14 | $0.56 | ||
| Q3 24 | $0.33 | $0.34 | ||
| Q2 24 | $0.40 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $122.7M |
| Total DebtLower is stronger | — | $750.4M |
| Stockholders' EquityBook value | $779.3M | $608.6M |
| Total Assets | $2.2B | $2.0B |
| Debt / EquityLower = less leverage | — | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $122.7M | ||
| Q4 25 | $429.5M | $121.0M | ||
| Q3 25 | $463.4M | $65.1M | ||
| Q2 25 | $342.1M | $96.9M | ||
| Q1 25 | $260.9M | $116.5M | ||
| Q4 24 | $290.8M | $114.7M | ||
| Q3 24 | $350.3M | $50.7M | ||
| Q2 24 | $327.7M | $38.3M |
| Q1 26 | — | $750.4M | ||
| Q4 25 | — | $720.3M | ||
| Q3 25 | — | $711.7M | ||
| Q2 25 | — | $690.2M | ||
| Q1 25 | — | $681.1M | ||
| Q4 24 | — | $688.7M | ||
| Q3 24 | — | $666.6M | ||
| Q2 24 | — | $660.8M |
| Q1 26 | — | $608.6M | ||
| Q4 25 | $779.3M | $604.3M | ||
| Q3 25 | $775.5M | $576.6M | ||
| Q2 25 | $765.5M | $557.7M | ||
| Q1 25 | $745.4M | $541.6M | ||
| Q4 24 | $712.7M | $537.6M | ||
| Q3 24 | $704.6M | $480.3M | ||
| Q2 24 | $678.9M | $461.9M |
| Q1 26 | — | $2.0B | ||
| Q4 25 | $2.2B | $2.0B | ||
| Q3 25 | $2.2B | $1.9B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.7B |
| Q1 26 | — | 1.23× | ||
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | — | 1.28× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | 1.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $38.3M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 0.7% |
| Cash ConversionOCF / Net Profit | -0.44× | 2.20× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $38.3M | ||
| Q4 25 | $-2.9M | $73.9M | ||
| Q3 25 | $10.0M | $-8.7M | ||
| Q2 25 | $90.9M | $14.5M | ||
| Q1 25 | $16.6M | $49.6M | ||
| Q4 24 | $-10.9M | $73.0M | ||
| Q3 24 | $34.0M | $19.8M | ||
| Q2 24 | $23.2M | $29.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $65.8M | ||
| Q3 25 | $7.4M | $-19.7M | ||
| Q2 25 | $89.5M | $4.5M | ||
| Q1 25 | $13.6M | $37.2M | ||
| Q4 24 | $-13.5M | $64.6M | ||
| Q3 24 | $31.7M | $11.8M | ||
| Q2 24 | $20.4M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 5.8% | ||
| Q3 25 | 0.8% | -1.9% | ||
| Q2 25 | 13.7% | 0.4% | ||
| Q1 25 | 2.2% | 3.9% | ||
| Q4 24 | -2.0% | 6.3% | ||
| Q3 24 | 6.6% | 1.3% | ||
| Q2 24 | 4.2% | 1.4% |
| Q1 26 | — | 0.7% | ||
| Q4 25 | 0.3% | 0.7% | ||
| Q3 25 | 0.3% | 1.1% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.5% | 1.3% | ||
| Q4 24 | 0.4% | 0.8% | ||
| Q3 24 | 0.5% | 0.9% | ||
| Q2 24 | 0.6% | 1.7% |
| Q1 26 | — | 2.20× | ||
| Q4 25 | -0.44× | 3.41× | ||
| Q3 25 | 26.69× | -0.46× | ||
| Q2 25 | 9.65× | 0.68× | ||
| Q1 25 | 2.48× | 4.82× | ||
| Q4 24 | — | 3.05× | ||
| Q3 24 | 2.11× | 1.41× | ||
| Q2 24 | 1.21× | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CHEF
Segment breakdown not available.
